Molded glass vials demonstrate robust CCI performance under deep-cold storage conditions🔄
 
Container closure integrity (CCI) is a critical quality attribute throughout the lifecycle of sterile pharmaceutical products, helping to ensure product integrity and patient safety. However, numerous studies have shown that deep-cold storage conditions can increase the risk of temporary CCI failures that may remain undetected using conventional testing methods such as blue dye testing. 

🏆 We are proud to share that SGD Pharma has been honored with the PAI Innovation in Sustainability Award 2026 during the PAI CFO & Sustainability Club held last week in London.

This recognition highlights the progress of our decarbonization roadmap and the innovative projects helping us accelerate the transition towards lower-carbon pharmaceutical glass manufacturing.

Great CCI FRANCE CHINE gala in Shanghai, with high in energy and a lot of connections with old and new friends ✨
 
Congratulations to Caroline PENARD and her team at the Chamber of Commerce and Industry France Chine for having organized such a powerful and creative moment.
 

❓ Have you ever wondered where the exquisite glass packaging for your favourite beauty essentials is produced?
 
For some of the world’s most coveted brands, it’s right here – at SGD Pharma’s Zhanjiang plant in China, our Center of Excellence for molded glass for Beauty & Care.
 

We are thrilled to announce that SGD Pharma will be exhibiting at CPHI China 2026!

We’re convinced that glass packaging can be beautiful, functional and more sustainable.
 
At SGD Pharma, the 3R principles, Reduce, Reuse and Recycle are at the heart of our innovation process. Three recent product developments illustrate this approach:
 
⚖️ Reduce: Our innovative NOVA lightweight glass bottles have an optimized design that maintains material strength while using less material, reducing CO2 emissions by 20% compared to standard bottles.